AFP2 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context of AFP2 Antibody

The term "AFP2 Antibody" refers to monoclonal or polyclonal antibodies targeting specific epitopes of alpha-fetoprotein (AFP), a glycoprotein with diagnostic and therapeutic relevance in oncology. AFP is a 70 kDa oncofetal antigen expressed during fetal development and re-emerges in hepatocellular carcinoma (HCC), germ cell tumors, and liver diseases . The "AFP2" designation typically denotes a specific antibody clone or variant optimized for applications such as ELISA, immunohistochemistry (IHC), or flow cytometry. For example, the AFP-2 tracer antibody (HRP-labeled) is a mouse monoclonal IgG1κ antibody used in sandwich ELISA assays to quantify human AFP levels .

Development and Specificity of AFP2 Antibodies

AFP2 antibodies are engineered for high specificity to AFP domains. Key characteristics include:

PropertyDetails
ImmunogenRecombinant human AFP or peptide fragments (e.g., AA 30-80 in radish defensin-like AFP2)
Host SpeciesMouse (monoclonal) or rabbit (polyclonal)
Cross-ReactivityHuman AFP; no cross-reactivity with normal serum proteins
ConjugateHRP, FITC, or fluorophore-labeled for detection
ApplicationsELISA, IHC, flow cytometry, Western blot

For instance, the MAB1369 antibody (Bio-Techne) detects AFP in HepG2 liver cancer cells via flow cytometry and immunofluorescence, with no reactivity in AFP-knockout cell lines .

Diagnostic Use

AFP2 antibodies are pivotal in:

  • Cancer Diagnosis: Elevated serum AFP levels (>400 ng/mL) correlate with HCC . The AFP-2 tracer antibody pairs with a capture antibody (e.g., AFP-Y1) in ELISA for high-sensitivity AFP quantification .

  • Therapeutic Monitoring: AFP levels track treatment efficacy in HCC (e.g., ADP-A2AFP T-cell therapy showed disease control in 64% of patients) .

Therapeutic Development

AFP-targeting antibodies under investigation include:

  • Radioimmunotherapy: ¹²⁵I-labeled anti-AFP antibodies reduced tumor size in 63.2% of HCC patients in early trials .

  • Immunotherapy: Anti-AFP CAR-T cells (ADP-A2AFP) induced complete responses in HCC .

Efficacy in HCC Management

  • A Phase 1 trial using ¹²⁵I-labeled anti-AFP antibodies reported a 31.6% response rate (CR + PR) and 47.1% 1-year survival in HCC patients :

ParameterTreatment Group (¹²⁵I)Control Groups (Chemotherapy)
Tumor Shrinkage Rate63.2% (12/19)≤28.6%
AFP Reduction Rate64.7% (11/17)≤46.6%
1-Year Survival47.1% (8/17)≤23.5%

Mechanistic Insights

  • AFP promotes HCC via immunosuppression and drug resistance . AFP2 antibodies disrupt these pathways by blocking AFP-receptor interactions or delivering conjugated toxins .

  • In autoimmune contexts, anti-AFP antibodies correlate with liver disease severity (23.3% in HCC vs. 4.9% in chronic hepatitis) .

Challenges and Future Directions

  • Specificity Limitations: Non-cancerous conditions (e.g., cirrhosis) can elevate AFP, necessitating adjunct tests like fucosylated AFP assays .

  • Emerging Technologies: siRNA targeting AFP genes and AFP-epitope vaccines aim to suppress tumor growth while minimizing systemic toxicity .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
AFP2 antibody; At1g13740 antibody; F21F23.17Ninja-family protein AFP2 antibody; ABI five-binding protein 2 antibody; ABI5-binding protein 2 antibody
Target Names
AFP2
Uniprot No.

Target Background

Function
AFP2 Antibody acts as a negative regulator of abscisic acid (ABA) response during germination. It achieves this by mediating the ubiquitin-mediated proteolysis of ABI5/DPBF1.
Gene References Into Functions
  1. Research indicates that AFP1 and AFP2, proteins that bind to ABI5/ABF, are involved in multiple mechanisms regulating the abscisic acid (ABA) response. PMID: 27942958
Database Links

KEGG: ath:AT1G13740

STRING: 3702.AT1G13740.1

UniGene: At.48184

Protein Families
Ninja family
Subcellular Location
Nucleus.

Q&A

What is AFP2 and why is it significant in plant research?

AFP2 (ABI5-BINDING PROTEIN2) is a critical protein involved in the regulation of flowering time in plants, particularly in Arabidopsis thaliana. It functions as a molecular coordinator that modulates flowering by interacting with CONSTANS (CO) and affecting the expression of FLOWERING LOCUS T (FT). AFP2 contains three functional domains—the EAR (ethylene-responsive element binding factor-associated amphiphilic repression) motif, NINJA (Novel Interactor of JAZ) motif, and JAS (JAZ-associated) motif—which facilitate its interactions with other proteins and its regulatory functions. Understanding AFP2 is significant because it reveals fundamental mechanisms of plant development and adaptation to environmental conditions .

What types of AFP2 antibodies are available for research purposes?

Researchers commonly utilize polyclonal and monoclonal antibodies against AFP2 for different experimental applications. Polyclonal antibodies recognize multiple epitopes and provide strong signals in various applications but may have higher background. Monoclonal antibodies offer high specificity to a single epitope, making them valuable for distinguishing between full-length AFP2 and its truncated versions lacking specific domains (AFP2∆E, AFP2∆N, or AFP2∆J). Custom antibodies against specific domains of AFP2 are also available for specialized research examining domain-specific interactions or functions .

How can I validate the specificity of my AFP2 antibody?

Validation of AFP2 antibody specificity is crucial before conducting experiments. The recommended validation protocol includes:

  • Western blot analysis using wild-type samples alongside afp2 mutant samples (the antibody should detect a band of appropriate molecular weight in wild-type but not in the mutant)

  • Testing the antibody against recombinant AFP2 protein expressed in E. coli

  • Performing immunoprecipitation followed by mass spectrometry to confirm the identity of pulled-down proteins

  • Using blocking peptides corresponding to the immunogen to confirm specificity

As demonstrated in the literature, a properly validated AFP2 antibody should specifically recognize endogenous AFP2 in wild-type samples but not in afp2 mutant samples .

How can AFP2 antibodies be used to investigate protein-protein interactions in flowering regulation?

AFP2 antibodies are powerful tools for investigating the complex protein-protein interactions involved in flowering regulation. Based on published research, you can employ the following approaches:

  • Co-immunoprecipitation (Co-IP): Use AFP2 antibodies to pull down AFP2 protein complexes, followed by western blotting with antibodies against suspected interaction partners (e.g., TPR2, CO). This technique successfully identified the AFP2-TPR2 interaction mediated by the EAR motif of AFP2 .

  • Chromatin Immunoprecipitation (ChIP): Use AFP2 antibodies to investigate whether AFP2 associates with specific genomic regions, particularly at the FT locus, to understand its role in chromatin modification and transcriptional regulation.

  • Yeast three-hybrid (Y3H) validation: While not directly using AFP2 antibodies, this complementary approach can confirm interactions observed in Co-IP experiments, as demonstrated in the identification of the CO-AFP2-TPR2 complex .

  • In vivo proximity labeling: Combine AFP2 antibodies with techniques like BioID or APEX to identify proteins in close proximity to AFP2 in living cells.

How can I use AFP2 antibodies to study post-translational modifications?

To investigate post-translational modifications (PTMs) of AFP2, consider these methodological approaches:

  • Phosphorylation-specific detection: Use general AFP2 antibodies for immunoprecipitation followed by phospho-specific antibodies or phosphoproteomic analysis to identify phosphorylation sites that may regulate AFP2 function.

  • Ubiquitination analysis: As AFP2 has been shown to affect the ubiquitin-mediated proteolysis of CO , you can use AFP2 antibodies to immunoprecipitate AFP2 and then probe for ubiquitin to assess whether AFP2 itself is regulated by ubiquitination.

  • Acetylation studies: Given AFP2's role in chromatin acetylation regulation at the FT locus , investigate whether AFP2 itself undergoes acetylation by immunoprecipitating with AFP2 antibodies and probing with anti-acetyl lysine antibodies.

  • Differential PTM analysis: Compare PTM patterns between wild-type and mutant plants, or between plants under different environmental conditions, to understand how PTMs affect AFP2 function in various contexts.

What controls should I include when using AFP2 antibodies in flowering time experiments?

When designing experiments investigating AFP2's role in flowering time regulation, include these essential controls:

  • Genetic controls: Include wild-type plants, afp2 mutants, and AFP2 overexpression lines to establish a baseline for antibody specificity and protein function .

  • Temporal controls: As CO protein accumulation follows a diurnal rhythm (peaking at ZT16), collect samples at multiple time points throughout the day/night cycle to accurately capture temporal dynamics .

  • Domain-specific controls: Include AFP2 variants lacking specific domains (AFP2∆E, AFP2∆N, AFP2∆J) to determine which domains are essential for specific interactions or functions .

  • Treatment controls: When using proteasome inhibitors like MG132 to study protein degradation, include appropriate vehicle controls and confirm inhibitor efficacy by monitoring known targets of proteasomal degradation .

  • Antibody controls: Include isotype controls and pre-immune serum controls to distinguish specific from non-specific binding.

What is the optimal protocol for immunoprecipitation using AFP2 antibodies?

Based on successful published protocols, here is an optimized immunoprecipitation method for AFP2:

  • Sample preparation: Harvest plant tissue (preferably at ZT16 when CO levels peak), flash-freeze in liquid nitrogen, and grind to a fine powder. Extract proteins in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, protease inhibitor cocktail, and phosphatase inhibitors if phosphorylation is being studied.

  • Pre-clearing: Incubate the lysate with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

  • Antibody incubation: Add AFP2 antibody (2-5 μg per 1 mg of total protein) and incubate overnight at 4°C with gentle rotation.

  • Bead capture: Add pre-washed protein A/G beads and incubate for 3 hours at 4°C.

  • Washing: Perform 4-5 washes with washing buffer (same as extraction buffer but with 0.1% Triton X-100).

  • Elution: Elute bound proteins by boiling in SDS sample buffer or using acidic glycine buffer for gentler elution.

  • Analysis: Analyze by western blotting or mass spectrometry depending on experimental goals.

For Co-IP experiments investigating the CO-AFP2-TPR2 complex, this protocol has been successfully used to demonstrate that CO-HA coprecipitates with TPR2 in the presence of full-length AFP2 but not in the presence of truncated AFP2 lacking the EAR or JAS domains .

How should AFP2 antibodies be used in chromatin immunoprecipitation (ChIP) experiments?

For effective ChIP experiments with AFP2 antibodies, follow these guidelines:

  • Crosslinking: Cross-link plants tissue with 1% formaldehyde for 10-15 minutes under vacuum, followed by quenching with 125 mM glycine.

  • Chromatin extraction and shearing: Extract chromatin and shear to fragments of 200-500 bp using sonication or enzymatic digestion.

  • Immunoprecipitation: Use 3-5 μg of AFP2 antibody per ChIP reaction, along with appropriate IgG controls.

  • Washing and elution: Perform stringent washes to remove non-specific binding, then elute DNA-protein complexes.

  • Reverse crosslinking and DNA purification: Reverse crosslinks and purify DNA for downstream analysis.

  • Analysis: Analyze by qPCR targeting specific regions of interest in the FT locus or by ChIP-seq for genome-wide binding profile.

This approach can help determine whether AFP2 directly associates with chromatin at the FT locus and how this association may change in response to different environmental conditions or genetic backgrounds.

What is the recommended protocol for western blot detection of AFP2?

For optimal western blot detection of AFP2, follow this protocol:

  • Sample preparation: Extract proteins from plant tissue in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, and protease inhibitors.

  • Gel electrophoresis: Separate 20-50 μg of total protein on a 10-12% SDS-PAGE gel.

  • Transfer: Transfer proteins to a PVDF membrane at 100V for 1 hour or 30V overnight at 4°C.

  • Blocking: Block the membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature.

  • Primary antibody incubation: Dilute AFP2 antibody 1:1000 to 1:5000 in blocking buffer and incubate overnight at 4°C.

  • Washing: Wash the membrane 3-4 times with TBST, 5 minutes each.

  • Secondary antibody: Incubate with HRP-conjugated secondary antibody (1:5000-1:10000) for 1 hour at room temperature.

  • Detection: Develop using enhanced chemiluminescence (ECL) substrate and image using a digital imaging system.

This protocol has been validated in studies examining AFP2 expression levels and its interaction with other proteins like TPR2 and CO .

How can I improve the signal-to-noise ratio when using AFP2 antibodies?

To improve signal-to-noise ratio when working with AFP2 antibodies, implement these strategies:

  • Antibody titration: Determine the optimal antibody concentration by testing a range of dilutions (1:500 to 1:5000) to find the best signal-to-noise ratio.

  • Blocking optimization: Test different blocking agents (BSA, non-fat dry milk, commercial blockers) and concentrations (3-5%) to reduce background.

  • Incubation conditions: Try different primary antibody incubation times and temperatures (4°C overnight vs. room temperature for 2 hours).

  • Washing stringency: Increase the number or duration of washes, or adjust detergent concentration in wash buffer to reduce non-specific binding.

  • Sample preparation: Include phosphatase inhibitors, deubiquitinase inhibitors, or protease inhibitors in your extraction buffer to preserve the native state of AFP2.

  • Signal amplification: Consider using signal amplification systems for low-abundance detection while maintaining specificity.

These optimizations have proven effective in enhancing the detection of AFP2 in complex plant extracts while minimizing background interference.

What are common pitfalls when interpreting AFP2 antibody results in flowering time studies?

Researchers should be aware of these potential pitfalls when interpreting AFP2 antibody results:

  • Diurnal expression patterns: AFP2's interaction partners like CO show strong diurnal oscillation patterns with peak expression at specific zeitgeber times (ZT). Failure to account for these temporal variations can lead to inconsistent or misleading results .

  • Genetic background effects: Different Arabidopsis ecotypes may show variations in AFP2 expression or function. Always specify the genetic background used and consider validating findings in multiple backgrounds.

  • Domain-specific functions: The three domains of AFP2 (EAR, NINJA, JAS) have distinct functions. Results obtained using truncated versions lacking specific domains should be interpreted with caution and compared with full-length protein results .

  • Antibody cross-reactivity: AFP2 belongs to a family of proteins with similar domains. Verify that your antibody does not cross-react with related proteins like AFP1, AFP3, or AFP4.

  • Environmental influences: Flowering time is highly responsive to environmental conditions. Control and report growing conditions meticulously, as AFP2 function may vary under different photoperiods, temperatures, or stress conditions.

  • Technical artifacts: Be cautious about interpreting results from overexpression studies, as artificially high levels of AFP2 may create non-physiological interactions or phenotypes.

What alternative approaches can I use if AFP2 antibodies yield inconsistent results?

If you encounter inconsistent results with AFP2 antibodies, consider these alternative approaches:

  • Epitope-tagged AFP2: Generate transgenic plants expressing AFP2 fused to epitope tags (HA, FLAG, GFP) for which highly specific commercial antibodies are available .

  • Proximity labeling: Use BioID or APEX2 fused to AFP2 to identify interaction partners without relying on antibody-based co-immunoprecipitation.

  • Mass spectrometry: Use targeted proteomics approaches to detect and quantify AFP2 and its interacting partners directly.

  • Genetic approaches: Utilize genetic interaction studies (double mutants, suppressor screens) to validate biochemical findings.

  • In vitro binding assays: Complement antibody-based approaches with in vitro techniques using recombinant proteins, such as pull-down assays with purified components .

  • Reporter gene assays: Use transcriptional reporters for AFP2 target genes (like FT) to monitor AFP2 activity indirectly .

These alternative approaches have been successfully employed in the literature to overcome limitations of antibody-based methods and provide complementary evidence for AFP2 function.

How can AFP2 antibodies be used to study the relationship between flowering and stress responses?

AFP2 was initially identified as an ABI5-binding protein involved in abscisic acid signaling during seed germination. To investigate the crosstalk between flowering and stress responses using AFP2 antibodies:

  • Stress-induced complex formation: Use AFP2 antibodies for co-immunoprecipitation experiments under various stress conditions (drought, cold, heat) to identify stress-specific interaction partners.

  • Chromatin association dynamics: Perform ChIP experiments with AFP2 antibodies to determine whether stress conditions alter AFP2's association with chromatin at the FT locus or other target genes.

  • Post-translational modifications: Compare AFP2 post-translational modifications under normal and stress conditions using immunoprecipitation followed by mass spectrometry.

  • Protein stability analysis: Monitor AFP2 protein levels using antibodies in time-course experiments following stress application to determine if stress affects AFP2 stability.

  • Subcellular localization: Use AFP2 antibodies for immunofluorescence studies to track changes in subcellular localization in response to stress signals.

This approach can provide valuable insights into how plants integrate environmental stress signals with developmental timing through AFP2-mediated mechanisms.

What insights can AFP2 antibodies provide about the evolutionary conservation of flowering mechanisms across plant species?

AFP2 antibodies can be valuable tools for comparative studies across plant species:

  • Cross-species reactivity testing: Test AFP2 antibodies against protein extracts from diverse plant species to identify conserved epitopes and potential orthologs.

  • Functional conservation analysis: Use AFP2 antibodies to immunoprecipitate complexes from different plant species and identify conserved interaction partners through mass spectrometry.

  • Structural conservation mapping: Compare immunoreactivity patterns of domain-specific AFP2 antibodies across species to map structurally conserved regions.

  • Developmental timing comparison: Use AFP2 antibodies to monitor protein expression patterns throughout development in different species to identify conserved regulatory mechanisms.

  • Heterologous complementation validation: In complementation studies where AFP2 from one species is expressed in another, use species-specific antibodies to confirm proper expression and function.

This comparative approach can reveal evolutionary conservation and divergence in flowering time regulation across plant lineages.

How might AFP2 antibodies contribute to crop improvement research?

AFP2 antibodies can accelerate crop improvement research in several ways:

  • Transfer of knowledge to crops: Use AFP2 antibodies to identify and characterize orthologs in important crop species, potentially enabling the manipulation of flowering time to improve yield or stress resilience.

  • Molecular marker development: Information gained from AFP2 antibody studies can guide the development of molecular markers associated with favorable flowering traits.

  • Validation of gene editing outcomes: Use AFP2 antibodies to confirm protein-level changes resulting from gene editing approaches targeting AFP2 or its regulatory network.

  • Protein-level phenotyping: Develop high-throughput immunoassays using AFP2 antibodies to screen germplasm collections for natural variation in AFP2 protein levels or modification patterns.

  • Environmental adaptation studies: Apply AFP2 antibodies to study how different cultivars or landraces modulate AFP2 function in response to different environments, identifying adaptive mechanisms for climate resilience.

By bridging fundamental research with applied crop science, AFP2 antibodies can contribute to developing crops with optimized flowering time and improved adaptation to changing climatic conditions.

Table 1: Comparative Analysis of AFP2 Detection Methods

Detection MethodSensitivitySpecificitySample RequirementsBest ApplicationsLimitations
Western BlotMedium-HighHigh20-50 μg total proteinProtein expression levels, MW verificationLimited spatial information
ImmunoprecipitationHighMedium-High0.5-1 mg total proteinProtein-protein interactions, PTM analysisRequires native protein folding
ChIPMediumMedium-High~10^7 cellsDNA-binding sites, chromatin associationIndirect measurement of binding
ImmunofluorescenceMediumMediumFixed tissue sectionsSubcellular localization, tissue expressionPotential fixation artifacts
ELISAHighHigh5-10 μg total proteinQuantitative measurementLimited information on interactors
Flow CytometryHighMedium-HighSingle-cell suspensionsSingle-cell analysisLimited to suitable cell types

Table 2: AFP2 Domain Structure and Functional Significance

DomainPositionFunctionInteraction PartnersEffect on FloweringDetection Considerations
EAR MotifN-terminalMediates interaction with TPR2TPR2Required for flowering repressionEssential for CO-AFP2-TPR2 complex formation
NINJA MotifCentralUnknown for floweringUnknownDispensable for CO-TPR2 interactionNot required for TPR2 binding
JAS MotifC-terminalMediates interaction with COCORequired for flowering repressionEssential for CO-AFP2-TPR2 complex formation

Table 3: Troubleshooting Guide for Common AFP2 Antibody Issues

ProblemPossible CausesSolutionsValidation Approach
No signal in Western blotLow expression level, protein degradationIncrease protein amount, add protease inhibitors, optimize extractionTest with overexpression samples as positive control
Multiple bandsCross-reactivity, degradation productsIncrease antibody specificity, optimize extraction conditionsVerify with afp2 knockout samples
High backgroundNon-specific binding, excessive antibodyOptimize blocking, reduce antibody concentration, increase washesInclude blocking peptide controls
Failed co-IPWeak/transient interaction, harsh conditionsUse crosslinking, optimize buffer conditions, reduce wash stringencyValidate with known interactors (CO, TPR2)
Inconsistent ChIP resultsVariable crosslinking, low abundanceOptimize crosslinking time, increase starting materialInclude positive control regions
Poor reproducibilityDiurnal expression patternsStandardize harvest time (ZT16 recommended for CO interaction)Include time-course experiments

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.